Literature DB >> 11500191

Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure.

M Aviram1, L Dornfeld.   

Abstract

Consumption of pomegranate juice which is rich in tannins, possess anti-atherosclerotic properties which could be related to its potent anti-oxidative characteristics. As some antioxidants were recently shown to reduce blood pressure, we studied the effect of pomegranate juice consumption (50 ml, 1.5mmol of total polyphenols per day, for 2 weeks) by hypertensive patients on their blood pressure and on serum angiotensin converting enzyme (ACE) activity. A 36% decrement in serum ACE activity and a 5% reduction in systolic blood pressure were noted. Similar dose-dependent inhibitory effect (31%) of pomegranate juice on serum ACE activity was observed also in vitro. As reduction in serum ACE activity, even with no decrement in blood pressure, was previously shown to attenuate atherosclerosis, pomegranate juice can offer a wide protection against cardiovascular diseases which could be related to its inhibitory effect on oxidative stress and on serum ACE activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11500191     DOI: 10.1016/s0021-9150(01)00412-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  71 in total

1.  Effects of pomegranate juice supplementation on pulse wave velocity and blood pressure in healthy young and middle-aged men and women.

Authors:  Anthony Lynn; Hiba Hamadeh; Wing Chi Leung; Jean M Russell; Margo E Barker
Journal:  Plant Foods Hum Nutr       Date:  2012-09       Impact factor: 3.921

2.  Improvement of hypertension, endothelial function and systemic inflammation following short-term supplementation with red beet (Beta vulgaris L.) juice: a randomized crossover pilot study.

Authors:  S Asgary; M R Afshani; A Sahebkar; M Keshvari; M Taheri; E Jahanian; M Rafieian-Kopaei; F Malekian; N Sarrafzadegan
Journal:  J Hum Hypertens       Date:  2016-06-09       Impact factor: 3.012

Review 3.  A review and critical analysis of the scientific literature related to 100% fruit juice and human health.

Authors:  Dianne A Hyson
Journal:  Adv Nutr       Date:  2015-01-15       Impact factor: 8.701

Review 4.  Nutraceuticals and Blood Pressure Control: Results from Clinical Trials and Meta-Analyses.

Authors:  Arrigo F G Cicero; Alessandro Colletti
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-03-19

5.  Acute effects of pomegranate extract on postprandial lipaemia, vascular function and blood pressure.

Authors:  Aarati Susan Mathew; Gabriella M Capel-Williams; Sarah E E Berry; Wendy L Hall
Journal:  Plant Foods Hum Nutr       Date:  2012-12       Impact factor: 3.921

6.  Inhibition of nonenzymatic protein glycation by pomegranate and other fruit juices.

Authors:  Pamela Garner Dorsey; Phillip Greenspan
Journal:  J Med Food       Date:  2014-01-16       Impact factor: 2.786

7.  Long-term metabolic effects of different doses of niacin-bound chromium on Sprague-Dawley rats.

Authors:  N V Perricone; D Bagchi; B Echard; Harry G Preuss
Journal:  Mol Cell Biochem       Date:  2009-12-11       Impact factor: 3.396

Review 8.  Functional foods-based diet as a novel dietary approach for management of type 2 diabetes and its complications: A review.

Authors:  Parvin Mirmiran; Zahra Bahadoran; Fereidoun Azizi
Journal:  World J Diabetes       Date:  2014-06-15

9.  Effect of olive oil phenolic compounds on the expression of blood pressure-related genes in healthy individuals.

Authors:  Sandra Martín-Peláez; Olga Castañer; Valentini Konstantinidou; Isaac Subirana; Daniel Muñoz-Aguayo; Gemma Blanchart; Sonia Gaixas; Rafael de la Torre; Magí Farré; Guillermo T Sáez; Kristina Nyyssönen; Hans Joachim Zunft; Maria Isabel Covas; Montse Fitó
Journal:  Eur J Nutr       Date:  2015-12-12       Impact factor: 5.614

10.  Maitake mushroom extracts ameliorate progressive hypertension and other chronic metabolic perturbations in aging female rats.

Authors:  Harry G Preuss; Bobby Echard; Debasis Bagchi; Nicholas V Perricone
Journal:  Int J Med Sci       Date:  2010-06-07       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.